PreciVax Therapeutics Overview
- Headquarters
- Hong Kong, Hk
- Industry
- Biotechnology Research
- Employees
- 6
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About PreciVax Therapeutics
PreciVax Therapeutics is the first company in HK developing innovative vaccines for drug resistant bacterial infections. Our first product is a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).
Compare Similar Companies to PreciVax Therapeutics
Syntiron
Biotechnology Research
Delonix Bioworks
Biotechnology Research
ID-Antigens
Biotechnology Research
VaxEng
Pharmaceutical Manufacturing
AbVacc
Biotechnology Research
AltHost Consortium
Biotechnology Research
BactiVax ITN
Research Services
BAXERNA
Biotechnology Research
Hafion, Inc.
Biotechnology Research
ReNewVax Ltd
Biotechnology Research